Show simple item record

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

dc.contributor.authorFendler, A
dc.contributor.authorShepherd, STC
dc.contributor.authorAu, L
dc.contributor.authorWilkinson, KA
dc.contributor.authorWu, M
dc.contributor.authorByrne, F
dc.contributor.authorCerrone, M
dc.contributor.authorSchmitt, AM
dc.contributor.authorJoharatnam-Hogan, N
dc.contributor.authorShum, B
dc.contributor.authorTippu, Z
dc.contributor.authorRzeniewicz, K
dc.contributor.authorBoos, LA
dc.contributor.authorHarvey, R
dc.contributor.authorCarlyle, E
dc.contributor.authorEdmonds, K
dc.contributor.authorDel Rosario, L
dc.contributor.authorSarker, S
dc.contributor.authorLingard, K
dc.contributor.authorMangwende, M
dc.contributor.authorHolt, L
dc.contributor.authorAhmod, H
dc.contributor.authorKorteweg, J
dc.contributor.authorFoley, T
dc.contributor.authorBazin, J
dc.contributor.authorGordon, W
dc.contributor.authorBarber, T
dc.contributor.authorEmslie-Henry, A
dc.contributor.authorXie, W
dc.contributor.authorGerard, CL
dc.contributor.authorDeng, D
dc.contributor.authorWall, EC
dc.contributor.authorAgua-Doce, A
dc.contributor.authorNamjou, S
dc.contributor.authorCaidan, S
dc.contributor.authorGavrielides, M
dc.contributor.authorMacRae, J
dc.contributor.authorKelly, G
dc.contributor.authorPeat, K
dc.contributor.authorKelly, D
dc.contributor.authorMurra, A
dc.contributor.authorKelly, K
dc.contributor.authorO'Flaherty, M
dc.contributor.authorDowdie, L
dc.contributor.authorAsh, N
dc.contributor.authorGronthoud, F
dc.contributor.authorShea, RL
dc.contributor.authorGardner, G
dc.contributor.authorMurray, D
dc.contributor.authorKinnaird, F
dc.contributor.authorCui, W
dc.contributor.authorPascual, J
dc.contributor.authorRodney, S
dc.contributor.authorMencel, J
dc.contributor.authorCurtis, O
dc.contributor.authorStephenson, C
dc.contributor.authorRobinson, A
dc.contributor.authorOza, B
dc.contributor.authorFarag, S
dc.contributor.authorLeslie, I
dc.contributor.authorRogiers, A
dc.contributor.authorIyengar, S
dc.contributor.authorEthell, M
dc.contributor.authorMessiou, C
dc.contributor.authorCunningham, D
dc.contributor.authorChau, I
dc.contributor.authorStarling, N
dc.contributor.authorTurner, N
dc.contributor.authorWelsh, L
dc.contributor.authorvan As, N
dc.contributor.authorJones, RL
dc.contributor.authorDroney, J
dc.contributor.authorBanerjee, S
dc.contributor.authorTatham, KC
dc.contributor.authorO'Brien, M
dc.contributor.authorHarrington, K
dc.contributor.authorBhide, S
dc.contributor.authorOkines, A
dc.contributor.authorReid, A
dc.contributor.authorYoung, K
dc.contributor.authorFurness, AJS
dc.contributor.authorPickering, L
dc.contributor.authorSwanton, C
dc.contributor.authorGandhi, S
dc.contributor.authorGamblin, S
dc.contributor.authorBauer, DL
dc.contributor.authorKassiotis, G
dc.contributor.authorKumar, S
dc.contributor.authorYousaf, N
dc.contributor.authorJhanji, S
dc.contributor.authorNicholson, E
dc.contributor.authorHowell, M
dc.contributor.authorWalker, S
dc.contributor.authorWilkinson, RJ
dc.contributor.authorLarkin, J
dc.contributor.authorTurajlic, S
dc.date.accessioned2021-12-15T16:04:55Z
dc.date.available2021-12-15T16:04:55Z
dc.date.issued2021-10-27
dc.identifierhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000712508700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9
dc.identifier.citationNATURE CANCER, 2021, pp. ? - ? (31)
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4928
dc.identifier.eissn2662-1347
dc.identifier.doi10.1038/s43018-021-00274-w
dc.format.extent? - ? (31)
dc.languageeng
dc.language.isoeng
dc.publisherNATURE PORTFOLIO
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectOncology
dc.subjectCOVID-19 VACCINATION
dc.subjectIMMUNOGENICITY
dc.subjectMALIGNANCIES
dc.subjectDEMOGRAPHICS
dc.subjectVACCINES
dc.titleAdaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
dc.typeJournal Article
dcterms.dateAccepted2021-10-27
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1038/s43018-021-00274-w
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2021-10-27
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfNATURE CANCER
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/ImmNet
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Molecular Oncology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Gastrointestinal Cancers Clinical Trials
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Gastrointestinal Cancers Clinical Trials/Gastrointestinal Cancers Clinical Trials (hon.)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)/Medicine (RMH Smith Cunningham) (hon.)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Melanoma and Kidney Cancer
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Treatment of thoracic tumours
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Treatment of thoracic tumours/Treatment of thoracic tumours (hon.)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR/Students
pubs.organisational-group/ICR/Students/MD(Res)
pubs.organisational-group/ICR/Students/MD(Res)/Starting Cohort 20/21
pubs.organisational-group/ICR/Students/PhD and MPhil
pubs.organisational-group/ICR/Students/PhD and MPhil/17/18 Starting Cohort
pubs.organisational-group/ICR/Students/PhD and MPhil/18/19 Starting Cohort
pubs.publication-statusPublished
pubs.embargo.termsNot known
icr.researchteamMolecular Oncology
icr.researchteamGastrointestinal Cancers Clinical Trials
icr.researchteamMedicine (RMH Smith Cunningham)
icr.researchteamMelanoma and Kidney Cancer
icr.researchteamTreatment of thoracic tumours
icr.researchteamTargeted Therapy
dc.contributor.icrauthorShepherd, Scott
dc.contributor.icrauthorCunningham, David
dc.contributor.icrauthorChau, Ian
dc.contributor.icrauthorJhanji, Shaman
dc.contributor.icrauthorHarrington, Kevin
dc.contributor.icrauthorTurner, Nicholas
dc.contributor.icrauthorO'Brien, Mary
dc.contributor.icrauthorStarling, Naureen
dc.contributor.icrauthorMessiou, Christina
dc.contributor.icrauthorAu, Lewis
dc.contributor.icrauthorPascual, Javier
dc.contributor.icrauthorTurajlic, Samra
dc.contributor.icrauthorFurness, Andrew
dc.contributor.icrauthorCurtis, Olivia


Files in this item

Thumbnail
Name:
Adaptive immunity and neutralizing ...
Size:
10.68Mb
Format:
PDF
Description:
Published version
View/Open

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0